Bronkaid LS-SYP

COMPOSITION : Ambroxol 30 mg + Guaiphenesin 50 mg + Levosalbutamol 1 mg

Description

Product Description

BRONKAID-LS Syrup is a combination respiratory formulation containing Ambroxol Hydrochloride, Guaiphenesin and Levosalbutamol. The combination brings together mucolytic, expectorant and bronchodilator actions and is formulated as an oral syrup.

It is supplied in a 100 mL bottle.

Therapeutic Information

Therapeutic Category

Respiratory / Cough & Expectorant

Drug Classes

Ingredient Pharmacological role
Ambroxol Hydrochloride Mucolytic
Guaiphenesin Expectorant
Levosalbutamol β₂-adrenergic bronchodilator

General therapeutic role

  • Ambroxol helps reduce the viscosity of respiratory mucus.
  • Guaiphenesin promotes the clearance of respiratory secretions.
  • Levosalbutamol produces bronchodilation by stimulating β₂-adrenergic receptors.

This makes the combination relevant to productive cough associated with bronchospasm/airway obstruction, when clinically appropriate.

Additional information
Composition

Ambroxol Hydrochloride 30 mg + Guaiphenesin 50 mg + Levosalbutamol 1 mg

Dosage Form

Syrup

Pack size

100 mL

Therapeutic Segment

Respiratory

Route

Oral

Therapeutic Category

Cough & Expectorant

MRP

₹120/-

Origin

India